ADCR Consortium
Granted Authorisations
Granted ADCR Authorisations in EU and in GB/UK
All submitted ADCR dossiers, to ECHA in the EU, and to HSE in the UK have been granted 12 year authorisation review periods from the European Commission and Defra in the UK.
ADCR have collated the status of all authorisation decisions with links to the decisions and additional information. The collected information also provides information on dossiers that have been submitted and that are still undergoing the assessment by the authorities.
The information is found in the ADCR Communication ‘Summary of ADCR applications submitted in EU and GB and decisions status’ (pdf, version 30 April 2025).
It is to be noted, that under EU REACH, as ADCR have submitted Tranche 2 dossiers to ECHA that are currently undergoing the authorisation process, the use of chromates can continue based on transitional arrangement measures according to REACH Article 61.1, even beyond January 22, 2026, and until a final vote is made. This may be impacted by the ongoing Cr(VI) Restriction process. For more information on this process, please see European Commission Q&A document 'Towards a restriction of Cr(VI) substances under REACH (version 25 August, 2025)
In the UK, ADCR has submitted Tranche 2 dossiers as well, and transitional measures, according to UK REACH Article 61.1 are in place for the submitted review reports, thus the uses covered by the review reports can continue until Defra has made its decisions (see Summary document linked above).